Azitra (AZTR) Operating Expenses (2022 - 2026)
Azitra (AZTR) posted Operating Expenses of $3.9 million for Q1 2026, up 76.68% on a QoQ basis from $2.2 million in Q4 2025, and up 26.89% year-over-year from $3.1 million in Q1 2025.
Azitra (AZTR) Operating Expenses (2022 - 2026) Analysis & Trends
Azitra's Operating Expenses history runs 5 years deep, the most recent figure standing at $3.9 million for Q1 2026.
- Quarterly Operating Expenses rose 26.89% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.8 million (up 6.01% YoY) and the FY2025 annual result came in at $11.0 million, changed 0.24% from the prior year.
- Operating Expenses was $3.9 million for Q1 2026 at Azitra, up from $2.2 million in the prior quarter.
- Across five years, Operating Expenses topped out at $3.9 million in Q1 2026 and bottomed at $1.6 million in Q2 2023.
- A 5-year average of $2.6 million and a median of $2.6 million in 2023 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2023 — Operating Expenses declined 26.4% — and 2024, when it surged 77.12%.
- Azitra's Operating Expenses stood at $2.7 million in 2022, then slipped by 6.16% to $2.6 million in 2023, then dropped by 4.93% to $2.4 million in 2024, then retreated by 8.53% to $2.2 million in 2025, then jumped by 76.68% to $3.9 million in 2026.
- Business Quant data shows AZTR's Operating Expenses at $3.9 million in Q1 2026, $2.2 million in Q4 2025, and $2.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,785.82 Bn | 1,785.76 Bn | - | - |
| 2 | Akari Therapeutics | 979.03 Bn | 979.03 Bn | - | 15.76 Mn |
| 3 | BeOne Medicines | 473.13 Bn | 468.34 Bn | 1.35 Bn | 1.10 Bn |
| 4 | Vertex Pharmaceuticals | 123.67 Bn | 116.43 Bn | 2.59 Bn | 1.85 Bn |
| 5 | Regeneron Pharmaceuticals | 71.57 Bn | 62.81 Bn | 3.31 Bn | 2.96 Bn |
| 6 | Belite Bio | 62.00 Bn | 62.00 Bn | - | 32.68 Mn |
| 7 | Argenx Se | 54.61 Bn | 49.42 Bn | 1.41 Bn | 2.89 Bn |
| 8 | Alnylam Pharmaceuticals | 37.99 Bn | 34.98 Bn | 959.66 Mn | 898.54 Mn |
| 9 | Revolution Medicines | 36.09 Bn | 36.09 Bn | - | 445.22 Mn |
| 10 | Azitra | 2.07 Mn | 2.07 Mn | - | 3.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.93 Mn |
| Dec 31, 2025 | 2.23 Mn |
| Sep 30, 2025 | 2.77 Mn |
| Jun 30, 2025 | 2.87 Mn |
| Mar 31, 2025 | 3.10 Mn |
| Dec 31, 2024 | 2.43 Mn |
| Sep 30, 2024 | 2.93 Mn |
| Jun 30, 2024 | 2.67 Mn |
| Mar 31, 2024 | 2.96 Mn |
| Dec 31, 2023 | 2.56 Mn |
| Sep 30, 2023 | 2.30 Mn |
| Jun 30, 2023 | 1.60 Mn |
| Mar 31, 2023 | 1.67 Mn |
| Dec 31, 2022 | 2.73 Mn |
| Sep 30, 2022 | 2.42 Mn |
| Jun 30, 2022 | 2.17 Mn |